It perfectly explains what half a year of opening low and moving high is, in the strict sense of the word, from falling all the way down in the fourth quarter of last year to February, and starting at the end of February and March, almost all Bitcoin-related stocks achieved unprecedented returns (profit and profit). In the second half of the year, we will continue to cultivate our mentality, continue to look at cryptocurrencies and data centers, and hope to be able to implement some of the benefits![]()
Translated
![Summary of 2024](https://sgsnsimg.moomoo.com/sns_client_feed/102606536/20240702/b6046aea09959bb9c5474b81e5fd4a11.jpg?area=101&is_public=true)
![Summary of 2024](https://sgsnsimg.moomoo.com/sns_client_feed/102606536/20240702/02c6f5e44070ebc840cc221eacff4b3b.jpg?area=101&is_public=true)
6
量化喵喵
voted
Bitcoin recently regained its momentum and rebounded above $63,000 on Monday after hitting a low of $60,000 at the end of June. Despite facing various challenges such as a complex and ever-changing macro environment, sell-off shocks, and a slowdown in ETF demand, the cryptocurrency market is now experiencing new optimism with the increasing possibility of Republican presidential candidate Trump winning the 2024 preside...
![Bitcoin Bounces Back Above $63,000: Could Crypto Become the New 'Trump Trade'?](https://ussnsimg.moomoo.com/sns_client_feed/77777017/20240702/1719916853713-49cbdf47d6.png/thumb?area=100&is_public=true)
![Bitcoin Bounces Back Above $63,000: Could Crypto Become the New 'Trump Trade'?](https://ussnsimg.moomoo.com/sns_client_feed/77777017/20240702/1719916866853-a656dd000a.png/thumb?area=100&is_public=true)
51
9
量化喵喵
liked
$Legend Biotech(LEGN.US$ Legend Biotech shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and $77 price target.
$Mereo BioPharma(MREO.US$ Mereo BioPharma shares are trading higher following reports suggesting AstraZeneca is weighing a bid for Mereo BioPharma.
$Seagen(SGEN.US$ Seagen shares are trading higher following a WSJ report suggesting Merck and other unnamed suitors are eyeing a purchase of the company.
$Scholar Rock(SRRK.US$ Schola...
$Mereo BioPharma(MREO.US$ Mereo BioPharma shares are trading higher following reports suggesting AstraZeneca is weighing a bid for Mereo BioPharma.
$Seagen(SGEN.US$ Seagen shares are trading higher following a WSJ report suggesting Merck and other unnamed suitors are eyeing a purchase of the company.
$Scholar Rock(SRRK.US$ Schola...
3